image
Healthcare - Medical - Care Facilities - NASDAQ - US
$ 2.67
10.6 %
$ 202 M
Market Cap
-3.37
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one TOI stock under the worst case scenario is HIDDEN Compared to the current market price of 2.67 USD, The Oncology Institute, Inc. is HIDDEN

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one TOI stock under the base case scenario is HIDDEN Compared to the current market price of 2.67 USD, The Oncology Institute, Inc. is HIDDEN

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one TOI stock under the best case scenario is HIDDEN Compared to the current market price of 2.67 USD, The Oncology Institute, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart TOI

image
$3.0$3.0$2.5$2.5$2.0$2.0$1.5$1.5$1.0$1.0$0.5$0.5$0.0$0.0Nov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 Apr
FINANCIALS
393 M REVENUE
21.33%
-60.1 M OPERATING INCOME
21.94%
-64.7 M NET INCOME
22.16%
-26.5 M OPERATING CASH FLOW
26.92%
46.2 M INVESTING CASH FLOW
-26.23%
-3.49 M FINANCING CASH FLOW
49.00%
100 M REVENUE
0.37%
-11.9 M OPERATING INCOME
13.89%
-13.2 M NET INCOME
70.66%
4.19 M OPERATING CASH FLOW
113.93%
-1.76 M INVESTING CASH FLOW
-3.68%
-164 K FINANCING CASH FLOW
32.51%
Balance Sheet The Oncology Institute, Inc.
image
Current Assets 112 M
Cash & Short-Term Investments 49.7 M
Receivables 48.7 M
Other Current Assets 14.1 M
Non-Current Assets 60.3 M
Long-Term Investments 0
PP&E 37.7 M
Other Non-Current Assets 22.6 M
28.76 %28.19 %8.15 %21.81 %13.10 %Total Assets$172.7m
Current Liabilities 52.2 M
Accounts Payable 24.3 M
Short-Term Debt 6.8 M
Other Current Liabilities 21.1 M
Non-Current Liabilities 117 M
Long-Term Debt 23.2 M
Other Non-Current Liabilities 93.7 M
14.38 %4.02 %12.47 %13.73 %55.40 %Total Liabilities$169.1m
EFFICIENCY
Earnings Waterfall The Oncology Institute, Inc.
image
Revenue 393 M
Cost Of Revenue 0
Gross Profit 393 M
Operating Expenses 454 M
Operating Income -60.1 M
Other Expenses 4.54 M
Net Income -64.7 M
400m400m350m350m300m300m250m250m200m200m150m150m100m100m50m50m00(50m)(50m)(100m)(100m)393m0393m(454m)(60m)(5m)(65m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
100.00% GROSS MARGIN
100.00%
-15.28% OPERATING MARGIN
-15.28%
-16.44% NET MARGIN
-16.44%
-1801.70% ROE
-1801.70%
-37.44% ROA
-37.44%
-47.23% ROIC
-47.23%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis The Oncology Institute, Inc.
image
10m10m00(10m)(10m)(20m)(20m)(30m)(30m)(40m)(40m)(50m)(50m)(60m)(60m)(70m)(70m)20192019202020202021202120222022202320232024202420252025
Net Income -64.7 M
Depreciation & Amortization 6.29 M
Capital Expenditures -3.79 M
Stock-Based Compensation 11.2 M
Change in Working Capital 18.1 M
Others 13.8 M
Free Cash Flow -30.3 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets The Oncology Institute, Inc.
image
TOI has no price targets from Wall Street.
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 14
6. Ownership
Insider Ownership The Oncology Institute, Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
2.53 M USD 8
0-3 MONTHS
50 K USD 1
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Topicus.com Inc. Announces Release Date for First Quarter Results TORONTO, April 14, 2025 (GLOBE NEWSWIRE) -- Topicus.com Inc. (TSXV:TOI) announced today it intends to release its first quarter results on May 2, 2025. globenewswire.com - 2 weeks ago
Constellation Software Inc., Topicus.com Inc. and Lumine Group Inc. Announce Annual Meetings TORONTO, April 09, 2025 (GLOBE NEWSWIRE) -- The Topicus.com Inc. (“Topicus”) (TSXV:TOI) annual general meeting of shareholders will be held on Tuesday, May 13, 2025 at 8:00 a.m. EST using a virtual meeting format with proceedings conducted solely via live audio webcast. The Lumine Group Inc. (“Lumine Group”) (TSXV:LMN) annual general meeting of shareholders will be held on Tuesday, May 13, 2025 at 8:30 a.m. EST using a virtual meeting format with proceedings conducted solely via live audio webcast. The Constellation Software Inc. (“Constellation” or “CSI”) (TSX:CSU) annual meeting of shareholders will be held on Tuesday, May 13, 2025 at 9:00 a.m. EST using a virtual meeting format, with proceedings conducted solely via live audio webcast. globenewswire.com - 3 weeks ago
Constellation Software Inc., Topicus.com Inc. and Lumine Group Inc. Announce Annual Meetings TORONTO, April 09, 2025 (GLOBE NEWSWIRE) -- The Topicus.com Inc. (“Topicus”) (TSXV:TOI) annual general meeting of shareholders will be held on Tuesday, May 13, 2025 at 8:00 a.m. EST using a virtual meeting format with proceedings conducted solely via live audio webcast. The Lumine Group Inc. (“Lumine Group”) (TSXV:LMN) annual general meeting of shareholders will be held on Tuesday, May 13, 2025 at 8:30 a.m. EST using a virtual meeting format with proceedings conducted solely via live audio webcast. The Constellation Software Inc. (“Constellation” or “CSI”) (TSX:CSU) annual meeting of shareholders will be held on Tuesday, May 13, 2025 at 9:00 a.m. EST using a virtual meeting format, with proceedings conducted solely via live audio webcast. globenewswire.com - 3 weeks ago
TOI Launches Florida Oncology Network, a Fully Delegated Cancer Care Network, and Announces Four Additional Value-based Contracts in Q1 CERRITOS, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today proudly announced the launch of the Florida Oncology Network. This new fully delegated network will expand access to high-quality, coordinated cancer care for Florida residents. globenewswire.com - 1 month ago
The Oncology Institute, Inc. (TOI) Q4 2024 Earnings Call Transcript The Oncology Institute, Inc. (NASDAQ:TOI ) Q4 2024 Earnings Conference Call March 25, 2025 5:00 PM ET Company Participants Mark Hueppelsheuser - General Counsel Daniel Virnich - CEO Rob Carter - CFO Conference Call Participants Yuan Zhi - B. Riley Robert LeBoyer - NOBLE Capital Markets Operator Good afternoon, and welcome to The Oncology Institute's Fourth Quarter and Full-Year 2024 Earnings Conference Call. seekingalpha.com - 1 month ago
The Oncology Institute Reports Fourth Quarter and Full Year 2024 Financial Results and Guidance for 2025 CERRITOS, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its fourth quarter and year ended December 31, 2024. globenewswire.com - 1 month ago
The Oncology Institute Announces $16.5 million Private Placement CERRITOS, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today announced it has entered into a securities purchase agreement (the “Securities Purchase Agreement”) with accredited investors for a private placement that is expected to result in gross proceeds of approximately $16.5 million, before deducting placement agent fees and offering expenses (the “Private Placement”). The Private Placement includes participation from existing investors, as well as members of the Company's management team and Board of Directors and is expected to close on March 26, 2025, subject to customary closing conditions. globenewswire.com - 1 month ago
The Oncology Institute Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Conference Call CERRITOS, Calif., March 04, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI) one of the largest value-based oncology groups in the United States, today announced that the company will release its fourth quarter and full year 2024 financial results after the market close on Tuesday, March 25, 2025, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time). globenewswire.com - 1 month ago
Constellation Software Inc. and Topicus.Com Inc. Announce Results for Topicus.com Inc. for the Fourth Quarter and Year Ended December 31, 2024 TORONTO, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Topicus.com Inc. (TSXV:TOI) in a joint release with Constellation Software Inc. (TSX:CSU) today announced financial results for Topicus.com Inc. (“Topicus” or the “Company”) for the fourth quarter and year ended December 31, 2024. Please note that all amounts referred to in this press release are in Euros unless otherwise stated. globenewswire.com - 2 months ago
Topicus.com Inc. Announces Release Date for Fourth Quarter Results TORONTO, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Topicus.com Inc. (TSXV:TOI) announced today it intends to release its fourth quarter results on February 26, 2025. globenewswire.com - 2 months ago
Florida Blue enhances cancer care for thousands of members New program aims to improve patient outcomes, experience, and quality of life by streamlining access to affordable and high-quality oncology care New program aims to improve patient outcomes, experience, and quality of life by streamlining access to affordable and high-quality oncology care globenewswire.com - 4 months ago
Grapevine Saves The Oncology Institute Millions On Healthcare Supplies Proof that Digital Transformation and Smarter Supply Chains Can Massively Cut Costs Proof that Digital Transformation and Smarter Supply Chains Can Massively Cut Costs globenewswire.com - 5 months ago
8. Profile Summary

The Oncology Institute, Inc. TOI

image
COUNTRY US
INDUSTRY Medical - Care Facilities
MARKET CAP $ 202 M
Dividend Yield 0.00%
Description The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The company operates 67 clinic locations. The Oncology Institute, Inc. was founded in 2007 and is based in Cerritos, California.
Contact 18000 Studebaker Road, Cerritos, CA, 90703 https://theoncologyinstitute.com
IPO Date June 4, 2020
Employees 825
Officers Mr. Stephen Cella Senior Vice President of Finance Mr. Austin Lee Vice President of Accounting & Controller Dr. Daniel Virnich FACHE, M.B.A., M.D. Chief Executive Officer & Executive Director Mr. Robert Carter Chief Financial Officer Mr. Mark Hueppelsheuser Esq. General Counsel Mr. Richard Alan Barasch Chairman of the Board Mr. Jeremy N. Castle M.B.A. Chief Operations Officer Dr. Yale D. Podnos F.A.C.S., M.D., M.P.H. Chief Medical Officer Mr. Jordan McInerney Chief Development Officer